Revealing transcription factors during human pancreatic β cell development

Trends in Endocrinology and Metabolism

Volumn 25, Issue 8, 2014, Pages 407-414

  Conrad, Elizabeth ^a   Stein, Roland ^a   Hunter, Chad S ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetes mellitus; Epigenetics; Human; Organogenesis; Transcription factor

Indexed keywords

GLIS FAMILY ZINC FINGER 3 PROTEIN; HEPATOCYTE NUCLEAR FACTOR 1BETA; HEPATOCYTE NUCLEAR FACTOR 3BETA; HEPATOCYTE NUCLEAR FACTOR 6; INSULIN GENE ENHANCER PROTEIN 1; MOTOR NEURON AND PANCREAS HOMEOBOX 1 PROTEIN; NEUROGENIC DIFFERENTIATION FACTOR; NEUROGENIN 3; PANCREAS TRANSCRIPTION FACTOR 1A; REGULATORY FACTOR X6; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR GATA 6; TRANSCRIPTION FACTOR MAFA; TRANSCRIPTION FACTOR MAFB; TRANSCRIPTION FACTOR NKX2.2; TRANSCRIPTION FACTOR NKX6.1; TRANSCRIPTION FACTOR PAX4; TRANSCRIPTION FACTOR PAX6; TRANSCRIPTION FACTOR PDX 1; TRANSCRIPTION FACTOR SOX17; TRANSCRIPTION FACTOR SOX9; UNCLASSIFIED DRUG;

CELL FATE; CELL LINEAGE; CELL MATURATION; CELL SPECIFICITY; EMBRYONIC STEM CELL; ENDOCRINE CELL; EPIGENETICS; HUMAN; HUMAN CELL; MULTIPOTENT PANCREATIC PROGENITOR CELL; MULTIPOTENT STEM CELL; NONHUMAN; ORGANOGENESIS; PANCREAS CELL; PANCREAS ISLET BETA CELL; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TRANSCRIPTION REGULATION; EMBRYOLOGY; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PANCREAS ISLET; PHYSIOLOGY;

HUMANS; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; ORGANOGENESIS; TRANSCRIPTION FACTORS;

EID: 84904722292     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2014.03.013     Document Type: Review

References (95)

1. Muoio D.M., Newgard C.B. Mechanisms of disease: molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. Nat. Rev. Mol. Cell Biol. 2008, 9:193-205.
2. Cano D.A., et al. Transcriptional control of mammalian pancreas organogenesis. Cell. Mol. Life Sci. 2013, 10.1007/s00018-013-1510-2.
3. Pan F.C., Wright C. Pancreas organogenesis: from bud to plexus to gland. Dev. Dyn. 2011, 240:530-565.
4. Brissova M. Assessment of human pancreatic islet architecture and composition by laser scanning confocal microscopy. J. Histochem. Cytochem. 2005, 53:1087-1097.
5. Cabrera O., et al. The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:2334-2339.
6. Melloul D., et al. Regulation of insulin gene transcription. Diabetologia 2002, 45:309-326.
7. Dai C., et al. Islet-enriched gene expression and glucose-induced insulin secretion in human and mouse islets. Diabetologia 2011, 55:707-718.
8. Ashcroft F.M., Rorsman P. Diabetes mellitus and the β cell: the last ten years. Cell 2012, 148:1160-1171.
9. Piper K., et al. Beta cell differentiation during early human pancreas development. J. Endocrinol. 2004, 181:11-23.
10. Jennings R.E., et al. Development of the human pancreas from foregut to endocrine commitment. Diabetes 2013, 62:3514-3522.
11. Lyttle B.M., et al. Transcription factor expression in the developing human fetal endocrine pancreas. Diabetologia 2008, 51:1169-1180.
12. Jeon J., et al. Endocrine cell clustering during human pancreas development. J. Histochem. Cytochem. 2009, 57:811-824.
13. Gao N., et al. Dynamic regulation of Pdx1 enhancers by Foxa1 and Foxa2 is essential for pancreas development. Genes Dev. 2008, 22:3435-3448.
14. Spence J.R., et al. Sox17 regulates organ lineage segregation of ventral foregut progenitor cells. Dev. Cell 2009, 17:62-74.
15. Zhang H., et al. Multiple, temporal-specific roles for HNF6 in pancreatic endocrine and ductal differentiation. Mech. Dev. 2009, 126:958-973.
16. Horikawa Y., et al. Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY. Nat. Genet. 1997, 17:384-385.
17. Haumaitre C., et al. Lack of TCF2/vHNF1 in mice leads to pancreas agenesis. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:1490-1495.
18. Heimberg H., et al. Adult human pancreatic duct and islet cells exhibit similarities in expression and differences in phosphorylation and complex formation of the homeodomain protein Ipf-1. Diabetes 2000, 49:571-579.
19. Castaing M., et al. Ex vivo analysis of acinar and endocrine cell development in the human embryonic pancreas. Dev. Dyn. 2005, 234:339-345.
20. Ahlgren U., et al. The morphogenesis of the pancreatic mesenchyme is uncoupled from that of the pancreatic epithelium in IPF1/PDX1-deficient mice. Development 1996, 122:1409-1416.
21. + cells are islet progenitors and are distinct from duct progenitors. Development 2002, 129:2447-2457.
22. Stoffers D.A., et al. Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. Nat. Genet. 1997, 17:138-139.
23. Stoffers D.A., et al. Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nat. Genet. 1997, 15:106-110.
24. Brissova M. Reduced PDX-1 expression impairs islet response to insulin resistance and worsens glucose homeostasis. Am. J. Physiol. Endocrinol. Metab. 2004, 288:E707-E714.
25. Guo S., et al. Inactivation of specific β cell transcription factors in type 2 diabetes. J. Clin. Invest. 2013, 123:3305-3316.
26. Obata J., et al. p48 subunit of mouse PTF1 binds to RBP-Jkappa/CBF-1, the intracellular mediator of Notch signalling, and is expressed in the neural tube of early stage embryos. Genes Cells 2001, 6:345-360.
27. Sellick G.S., et al. Mutations in PTF1A cause pancreatic and cerebellar agenesis. Nat. Genet. 2004, 36:1301-1305.
28. Krapp A., et al. The bHLH protein PTF1-p48 is essential for the formation of the exocrine and the correct spatial organization of the endocrine pancreas. Genes Dev. 1998, 12:3752-3763.
29. Weedon M.N., et al. Recessive mutations in a distal PTF1A enhancer cause isolated pancreatic agenesis. Nat. Genet. 2014, 46:61-64.
30. Xuan S., et al. Pancreas-specific deletion of mouse Gata4 and Gata6 causes pancreatic agenesis. J. Clin. Invest. 2012, 122:3516-3528.
31. Garg V., et al. GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature 2003, 424:438-443.
32. McDonald E., et al. SOX9 regulates endocrine cell differentiation during human fetal pancreas development. Int. J. Biochem. Cell Biol. 2012, 44:72-83.
33. Piper K., et al. Novel SOX9 expression during human pancreas development correlates to abnormalities in Campomelic dysplasia. Mech. Dev. 2002, 116:223-226.
34. Sosa-Pineda B., et al. The Pax4 gene is essential for differentiation of insulin-producing beta cells in the mammalian pancreas. Nature 1997, 386:399-402.
35. Seymour P.A., et al. A dosage-dependent requirement for Sox9 in pancreatic endocrine cell formation. Dev. Biol. 2008, 323:19-30.
36. Sander M., et al. Homeobox gene Nkx6.1 lies downstream of Nkx2.2 in the major pathway of beta-cell formation in the pancreas. Development 2000, 127:5533-5540.
37. Hang Y., Stein R. MafA and MafB activity in pancreatic β cells. Trends Endocrinol. Metab. 2011, 22:364-373.
38. Schaffer A.E., et al. Nkx6.1 controls a gene regulatory network required for establishing and maintaining pancreatic beta cell identity. PLoS Genet. 2013, 9:e1003274.
39. Li H., et al. Selective agenesis of the dorsal pancreas in mice lacking homeobox gene Hlxb9. Nat. Genet. 1999, 23:67-70.
40. Flanagan S.E., et al. Analysis of transcription factors key for mouse pancreatic development establishes NKX2-2 and MNX1 mutations as causes of neonatal diabetes in man. Cell Metab. 2014, 19:146-154.
41. Bonnefond A., et al. Transcription factor gene MNX1 is a novel cause of permanent neonatal diabetes in a consanguineous family. Diabetes Metab. 2013, 39:276-280.
42. Stanger B.Z., et al. Organ size is limited by the number of embryonic progenitor cells in the pancreas but not the liver. Nature 2007, 445:886-891.
43. De Franco E., et al. GATA6 mutations cause a broad phenotypic spectrum of diabetes from pancreatic agenesis to adult-onset diabetes without exocrine insufficiency. Diabetes 2013, 62:993-997.
44. Bonnefond A., et al. GATA6 inactivating mutations are associated with heart defects and, inconsistently, with pancreatic agenesis and diabetes. Diabetologia 2012, 55:2845-2847.
45. Allen H.L., et al. GATA6 haploinsufficiency causes pancreatic agenesis in humans. Nat. Genet. 2012, 44:20-22.
46. Watt A.J., et al. Development of the mammalian liver and ventral pancreas is dependent on GATA4. BMC Dev. Biol. 2007, 7:37.
47. Gradwohl G., et al. neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:1607-1611.
48. Capito C., et al. Mouse muscle as an ectopic permissive site for human pancreatic development. Diabetes 2013, 62:3479-3487.
49. Rubio-Cabezas O., et al. Permanent neonatal diabetes and enteric anendocrinosis associated with biallelic mutations in NEUROG3. Diabetes 2011, 60:1349-1353.
50. Smith S.B., et al. Rfx6 directs islet formation and insulin production in mice and humans. Nature 2010, 463:775-780.
51. Taleb N., Polychronakos C. RFX6 is needed for the development and maintenance of the β-cell phenotype. Islets 2011, 3:291-293.
52. Plengvidhya N., et al. PAX4 mutations in Thais with maturity onset diabetes of the young. J. Clin. Endocrinol. Metab. 2007, 92:2821-2826.
53. Senée V., et al. Mutations in GLIS3 are responsible for a rare syndrome with neonatal diabetes mellitus and congenital hypothyroidism. Nat. Genet. 2006, 38:682-687.
54. Watanabe N., et al. A murine model of neonatal diabetes mellitus in Glis3-deficient mice. FEBS Lett. 2009, 583:2108-2113.
55. Kim Y-S., et al. Glis3 regulates neurogenin 3 expression in pancreatic beta-cells and interacts with its activator, Hnf6. Mol. Cells 2012, 34:193-200.
56. Polak M., et al. Early pattern of differentiation in the human pancreas. Diabetes 2000, 49:225-232.
57. Herrera P.L. Adult insulin- and glucagon-producing cells differentiate from two independent cell lineages. Development 2000, 127:2317-2322.
58. Sussel L., et al. Mice lacking the homeodomain transcription factor Nkx2.2 have diabetes due to arrested differentiation of pancreatic beta cells. Development 1998, 125:2213-2221.
59. Shimomura H., et al. Nonsense mutation of islet-1 gene (Q310X) found in a type 2 diabetic patient with a strong family history. Diabetes 2000, 49:1597-1600.
60. Ahlgren U., et al. Independent requirement for ISL1 in formation of pancreatic mesenchyme and islet cells. Nature 1997, 385:257-260.
61. Du A., et al. Islet-1 is required for the maturation, proliferation, and survival of the endocrine pancreas. Diabetes 2009, 58:2059-2069.
62. Gu C., et al. Pancreatic beta cells require NeuroD to achieve and maintain functional maturity. Cell Metab. 2010, 11:298-310.
63. Naya F.J., et al. Tissue-specific regulation of the insulin gene by a novel basic helix-loop-helix transcription factor. Genes Dev. 1995, 9:1009-1019.
64. Malecki M.T., et al. Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus. Nat. Genet. 1999, 23:323-328.
65. Rubio-Cabezas O., et al. Homozygous mutations in NEUROD1 are responsible for a novel syndrome of permanent neonatal diabetes and neurological abnormalities. Diabetes 2010, 59:2326-2331.
66. Sander M., et al. Genetic analysis reveals that PAX6 is required for normal transcription of pancreatic hormone genes and islet development. Genes Dev. 1997, 11:1662-1673.
67. Ahlqvist E., et al. A common variant upstream of the PAX6 gene influences islet function in man. Diabetologia 2011, 55:94-104.
68. D'Amour K.A., et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat. Biotechnol. 2006, 24:1392-1401.
69. Kroon E., et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat. Biotechnol. 2008, 26:443-452.
70. Ackermann A.M., Gannon M. Molecular regulation of pancreatic beta-cell mass development, maintenance, and expansion. J. Mol. Endocrinol. 2007, 38:193-206.
71. Zhou Q., et al. In vivo reprogramming of adult pancreatic exocrine cells to β-cells. Nature 2008, 455:627-632.
72. Yang Y.P., et al. Context-specific α-to-β-cell reprogramming by forced Pdx1 expression. Genes Dev. 2011, 25:1680-1685.
73. Collombat P., et al. The ectopic expression of Pax4 in the mouse pancreas converts progenitor cells into α and subsequently β cells. Cell 2009, 138:449-462.
74. Courtney M., et al. The inactivation of Arx in pancreatic α-cells triggers their neogenesis and conversion into functional β-like Cells. PLoS Genet. 2013, 9:e1003934.
75. Kojima H., et al. NeuroD-betacellulin gene therapy induces islet neogenesis in the liver and reverses diabetes in mice. Nat. Med. 2003, 9:596-603.
76. Ber I. Functional, persistent, and extended liver to pancreas transdifferentiation. J. Biol. Chem. 2003, 278:31950-31957.
77. + cells in the liver to insulin-secreting ducts. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:15336-15341.
78. Dhawan S., et al. Pancreatic β cell identity is maintained by DNA methylation-mediated repression of Arx. Dev. Cell 2011, 20:419-429.
79. Haumaitre C., et al. Histone deacetylase inhibitors modify pancreatic cell fate determination and amplify endocrine progenitors. Mol. Cell. Biol. 2008, 28:6373-6383.
80. Zalzman M., et al. Reversal of hyperglycemia in mice by using human expandable insulin-producing cells differentiated from fetal liver progenitor cells. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:7253-7258.
81. Zalzman M., et al. Differentiation of human liver-derived, insulin-producing cells toward the beta-cell phenotype. Diabetes 2005, 54:2568-2575.
82. Mauda-Havakuk M., et al. Ectopic PDX-1 expression directly reprograms human keratinocytes along pancreatic insulin-producing cells fate. PLoS ONE 2011, 6:e26298.
83. Pennarossa G., et al. Brief demethylation step allows the conversion of adult human skin fibroblasts into insulin-secreting cells. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:8948-8953.
84. Houbracken I., et al. Lineage tracing evidence for transdifferentiation of acinar to duct cells and plasticity of human pancreas. Gastroenterology 2011, 141. 731-741.
85. Heremans Y. Recapitulation of embryonic neuroendocrine differentiation in adult human pancreatic duct cells expressing neurogenin 3. J. Cell Biol. 2002, 159:303-312.
86. Swales N., et al. Plasticity of adult human pancreatic duct cells by neurogenin3-mediated reprogramming. PLoS ONE 2012, 7:e37055.
87. Lee J., et al. Expansion and conversion of human pancreatic ductal cells into insulin-secreting endocrine cells. Elife 2013, 2:e00940.
88. Spijker H.S., et al. Conversion of mature human β-cells into glucagon-producing α-cells. Diabetes 2013, 62:2471-2480.
89. Bramswig N.C., et al. Epigenomic plasticity enables human pancreatic α to β cell reprogramming. J. Clin. Invest. 2013, 123:1275-1284.
90. Xie R., et al. Dynamic chromatin remodeling mediated by polycomb proteins orchestrates pancreatic differentiation of human embryonic stem cells. Cell Stem Cell 2013, 12:224-237.
91. Teo A.K.K., et al. Derivation of human Induced pluripotent stem cells from patients with maturity onset diabetes of the young. J. Biol. Chem. 2013, 288:5353-5356.
92. McCluskey J.T., et al. Development and functional characterization of insulin-releasing human pancreatic beta cell lines produced by electrofusion. J. Biol. Chem. 2011, 286:21982-21992.
93. Ravassard P., et al. A genetically engineered human pancreatic β cell line exhibiting glucose-inducible insulin secretion. J. Clin. Invest. 2011, 121:3589-3597.
94. Pagliuca F.W., Melton D.A. How to make a functional β-cell. Development 2013, 140:2472-2483.
95. Shaw-Smith C., et al. GATA4 mutations are a cause of neonatal and childhood-onset diabetes. Diabetes 2014, published ahead of print April 2, 2014. 10.2337/db14-0061.